Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) Complexed with a peptide from human myelin basic protein

Journal of Experimental Medicine

Volumn 188, Issue 8, 1998, Pages 1511-1520

  Smith, Kathrine J ^a,b   Pyrdol, Jason ^c   Gauthier, Laurent ^c   Wiley, Don C ^a,b   Wucherpfennig, Kai W ^c,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Autoimmunity; Crystal structure; HLA DR2; Multiple sclerosis; Myelin basic protein

Indexed keywords

ALANINE; HLA DR2 ANTIGEN; HLA DR4 ANTIGEN; MYELIN BASIC PROTEIN; PHENYLALANINE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; BINDING SITE; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; HUMAN; HYDROPHOBICITY; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; T LYMPHOCYTE; X RAY CRYSTALLOGRAPHY;

BINDING SITES; CRYSTALLOGRAPHY, X-RAY; HLA-DR2 ANTIGEN; HUMANS; MYELIN BASIC PROTEINS; PROTEIN CONFORMATION;

EID: 0032547858     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.8.1511     Document Type: Article

References (56)

1. Todd, J.A., H. Acha-Orbea, J.I. Bell, N. Chao, Z. Fronek, C.O. Jacob, M. McDermott, A.A. Sinha, L. Timmerman, L. Steinman, and H.O. McDevitt. 1988. A molecular basis for MHC class II-associated autoimmunity. Science. 240:1003-1009.
2. Nepom, G.T., and H. Erlich. 1991. MHC class-II molecules and autoimmunity. Annu. Rev. Immunol. 9:493-525.
3. Davies, J.L., Y. Kawaguchi, S.T. Bennett, J.B. Copeman, H.J. Cordell, L.E. Pritchard, P.W. Reed, S.C.L. Gough, S.C. Jenkins, S.M. Palmer, et al. 1994. A genome-wide search for human type I diabetes susceptibility genes. Nature. 371:130-136.
4. The Multiple Sclerosis Study Group. 1996. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat. Genet. 13:469-471.
5. Sawcer, S., H.B. Jones, R. Feakes, J. Gray, N. Smaldon, J. Chataway, N. Robertson, D. Clayton, P.N. Goodfellow, and A. Compston. 1996. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat. Genet. 13:464-468.
6. Ebers, G.C., K. Kukay, D.E. Bulman, A.D. Sadovnick, G. Rice, C. Anderson, H. Armstrong, K. Cousin, R.B. Bell, W. Hader, et al. 1996. A full genome search in multiple sclerosis. Nat. Genet. 13:472-476.
7. Spielman, R.S., and N. Nathenson. 1982. The genetics of susceptibility to multiple sclerosis. Epidemol. Rev. 4:45-65.
8. Hillert, J., T. Kall, M. Vrethem, S. Fredrikson, M. Ohlson, and O. Olerup. 1994. The HLA-Dw2 haplotype segregates closely with multiple sclerosis in multiplex families. J. Neuroimmunol. 50:95-100.
9. Oksenberg, J.R., E. Seboun, and S.L. Hauser. 1996. Genetics of demyelinating diseases. Brain Pathol. 6:289-302.
10. Lehmann, P.V., T. Forsthuber, A. Miller, and E.E. Sercarz. 1992. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature. 358:155-157.
11. Steinman, L. 1996. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell. 85:299-302.
12. Linington, C., M. Bradl, H. Lassmann, C. Brunner, and K. Vass. 1988. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 130:443-454.
13. Schluesener, H.J., R.A. Sobel, C. Linington, and H.L. Weiner. 1987. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139:4016-4021.
14. Ota, K., M. Matsui, E.L. Milford, G.A. Mackin, H.L. Weiner, and D.A. Hafler. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 346:183-187.
15. Pette, M., K. Fujita, D. Wilkinson, D.M. Altmann, J. Trowsdale, G. Giegerich, A. Hinkkanen, J.T. Epplen, L. Kappos, and H. Wekerle. 1990. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA. 87:7968-7972.
16. Martin, R., D. Jaraquemada, M. Flerlage, J. Richert, J. Whitaker, E.O. Long, D.E. McFarlin, and H.F. McFarland. 1990. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J. Immunol. 145:540-548.
17. Wucherpfennig, K.W., A. Sette, S. Southwood, C. Oseroff, M. Matsui, J.L. Strominger, and D.A. Hafler. 1994. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J. Exp. Med. 179:279-290.
18. Valli, A., A. Sette, L. Kappos, C. Oseroff, J. Sidney, G. Miescher, M. Hochberger, E.D. Albert, and L. Adorini. 1993. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J. Clin. Invest. 91:616-628.
19. Allegretta, M., J.A. Nicklas, S. Sriram, and R.J. Albertini. 1990. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science. 247:718-721.
20. Wucherpfennig, K.W., J. Zhang, C. Witek, M. Matsui, K. Ota, and D.A. Hafler. 1994. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J. Immunol. 150:5581-5592.
21. Vandevyver, C., N. Mertens, P. van den Elsen, R. Medaer, J. Raus, and J. Zhang. 1995. Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence. Eur. J. Immunol. 25:958-968.
22. Scholz, C., K.T. Patton, D.E. Anderson, G.J. Freeman, and D.A. Hafler. 1998. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. J. Immunol. 160:1532-1538.
23. Kalandadze, A., M. Galleno, L. Foncerrado, J.L. Strominger, and K.W. Wucherpfennig. 1996. Expression of HLA-DR2 molecules: replacement of the hydrophobic transmembrane region by a leucine zipper dimerization motif allows the assembly and secretion of soluble DR αβ heterodimers. J. Biol. Chem. 271:20156-20162.
24. Kozono, H., J. White, J. Clements, P. Marrack, and J.W. Kappler. 1994. Functional soluble major histocompatibility proteins with covalently bound peptides. Nature. 369:151-154.
25. Otwinowski, Z. 1993. Data collection and processing. In Proceedings of CCP4 Study Weekend. L. Sawyer, N. Isaacs, and S. Bailey, editors. SERC Daresbury Laboratory, Warrington, UK. 56-62.
26. Navaza, J. and P. Saludjian. 1997. AMoRe: an automated molecular replacement program package. Methods Enzymol. 276:581-594.
27. Stern, L.J., J.H. Brown, T.S. Jardetzky, R. Urban, J.L. Strominger, and D.C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 368:215-221.
28. Brünger, A.T. 1992. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature. 355: 472-475.
29. Jones, T.A., J.Y. Zou, S.W. Cowan, and Kjeldgaard. 1991. Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A. 47:110-119.
30. Laskowski, R.A., M.W. MacArthur, O.S. Moss, and J.M. Thornton. 1993. Procheck: a program to check the stereo-chemical quality of protein structures. Journal of Applied Crystallography. 26:28-29.
31. Brown, J.H., T.S. Jardetzky, J.C. Gorga, L.J. Stern, R.G. Urban, J.L. Strominger, and D.C. Wiley. 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 364:33-39.
32. Ghosh, P., M. Amaya, E. Mellins, and D.C. Wiley. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature. 378:457-462.
33. Marsh, S.G.E., and J.G. Bodmer. 1995. HLA class II region nucleotide sequences. Tissue Antigens. 45:258-280.
34. Dessen, A., C.M. Lawrence, S. Cupo, D.M. Zaller, and D.C. Wiley. 1997. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity. 7:473-481.
35. Busch, R., C.M. Hill, J.D. Hayball, J.R. Lamb, and J.B. Rothbard. 1991. Effect of a natural polymorphism at residue 86 of the HLA-DR β chain on peptide binding. J. Immunol. 147:1292-1298.
36. Hammer, J., E. Bono, F. Gallazzi, C. Belunis, Z. Nagy, and F. Sinigaglia. 1994. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J. Exp. Med. 180:2353-2358.
37. Hammer, J., F. Gallazzi, E. Bono, R.W. Karr, J. Guenot, P. Valsasnini, Z.A. Nagy, and F. Sinigaglia. 1995. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J. Exp. Med. 181:1847-1855.
38. Fu, X.-T., C.P. Bono, S.L. Woulfe, C. Swearingen, N.L. Summers, F. Sinigaglia, A. Sette, B.D. Schwartz, and R.W. Karr. 1995. Pocket 4 of the HLA-DR(α,β1*0401) molecule is a major determinant of T cell recognition of peptide. J. Exp. Med. 181:915-926.
39. Fremont, D.H., W.A. Hendrickson, P. Marrack, and J. Kappler. 1996. Structures of an MHC class II molecule with covalently bound single peptides. Science. 272:1001-1004.
40. k in complex with a dominant epitope of lysozyme. Immunity. 8:305-317.
41. d-peptide complexes reveal that high affinity can be achieved without large anchor residues. Immunity. 8:319-329.
42. Wucherpfennig, K.W., and J.L. Strominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:695-705.
43. Garboczi, D.N., P. Ghosh, U. Utz, Q.R. Fan, W.E. Biddison, and D.C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature. 384:134-141.
44. Ding, Y.-H., K.J. Smith, D.M. Garboczi, U. Utz, W.E. Biddison, and D.C. Wiley. 1998. Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/tax peptide complex using different TCR amino acids. Immunity. 8:403-411.
45. Hemmer, B., B.T. Fleckenstein, M. Vergelli, G. Jung, H. McFarland, R. Martin, and K.-H. Wiesmüller. 1997. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J. Exp. Med. 185:1651-1659.
46. Gregerson, P.K., J. Silver, and R.J. Winchester. 1987. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30:1205-1213.
47. Scharf, S.J., A. Friedmann, C. Brautbar, F. Szafer, L. Steinman, G. Horn, U. Gyllensten, and H.A. Erlich. 1988. HLA class II allelic variation and susceptibility to pemphigus vulgaris. Proc. Natl. Acad. Sci. USA. 85:3504-3508.
48. Ahmed, A.R., E.J. Yunis, K. Khatri, R. Wagner, G. Notani, Z. Awed, and C. Alper. 1990. Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris. Proc. Natl. Acad. Sci. USA. 87:7658-7662.
49. Wucherpfennig, K.W., and J.L. Strominger. 1995. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J. Exp. Med. 181:1597-1601.
50. Fugger, L., J.B. Rothbard, and G. Sonderstrup-McDevitt. 1996. Specificity of an HLA-DRB1*0401-restricted T cell response to type II collagen. Eur. J. Immunol. 26:928-933.
51. Rosloniec, E.F., D.D. Brand, L.K. Myers, K.B. Whittington, M. Gumanovskaya, D.M. Zaller, A. Woods, D.M. Altmann, J.M. Stuart, and A.H. Kang. 1997. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J. Exp. Med. 185:1113-1122.
52. Bornstein, M.B., A. Miller, S. Slagle, M. Weitzman, H. Crystal, E. Drexler, M. Keilson, A. Merriam, S. Wassertheil-Smoller, V. Spada, et al. 1987. A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis. N. Engl. J. Med. 317:408-414.
53. Johnson, K.P., B.R. Brooks, J.A. Cohen, C.C. Ford, J. Goldstein, R.P. Lisak, L.W. Myers, H.S. Panitch, J.W. Rose, R.B. Schiffer, et al. 1995. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. Neurology. 45:1268-1276.
54. Fridkis-Hareli, M., and J.L. Strominger. 1998. Promiscuous binding of synthetic copolymer 1 to purified HLA-DR molecules. J. Immunol. 160:4386-4397.
55. Nicholls, A., K.A. Sharp, and B. Honig. 1991. GRASP, computer program. Proteins. 11:281-296.
56. Carson, M. 1991. Ribbons 2.0. Journal of Applied Crystallography. 24:958-961.